Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3

Maturitas

Volumn 51, Issue 3, 2005, Pages 286-293

  Duschek, Erik J J ^a   Gooren, Louis J ^a   Netelenbos, Coen ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Andropause; IGF 1; IGFBP 3; Raloxifene; Testosterone; Testosterone undecanoate

Indexed keywords

ESTRADIOL; ESTROGEN; GONADOTROPIN; PLACEBO; RALOXIFENE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SERUM; TESTOSTERONE BLOOD LEVEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGING; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RALOXIFENE; TESTOSTERONE; TRANSSEXUALISM;

EID: 20644459224     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.08.011     Document Type: Article

References (59)

1. A. Gray, H.A. Feldman, J.B. McKinlay, and C. Longcope Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study J Clin Endocrinol Metab 73 5 1991 1016 1025
2. S.M. Harman, E.J. Metter, J.D. Tobin, J. Pearson, and M.R. Blackman Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86 2 2001 724 731
3. E. Leifke, V. Gorenoi, C. Wichers, M.A. Von Zur, E. Von Buren, and G. Brabant Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort Clin Endocrinol (Oxford) 53 6 2000 689 695
4. J.R. Florini, P.N. Prinz, M.V. Vitiello, and R.L. Hintz Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone J Gerontol 40 1 1985 2 7
5. J.D. Veldhuis, A.Y. Liem, and S. South Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay J Clin Endocrinol Metab 80 11 1995 3209 3222
6. E. Corpas, S.M. Harman, and M.R. Blackman Human growth hormone and human aging Endocrinol Rev 14 1 1993 20 39
7. K.Y. Ho, W.S. Evans, and R.M. Blizzard Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations J Clin Endocrinol Metab 64 1 1987 51 58
8. K. Sjogren, J.L. Liu, and K. Blad Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice Proc Natl Acad Sci USA 96 12 1999 7088 7092
9. K.K. Ho, A.J. O'Sullivan, and D.M. Hoffman Metabolic actions of growth hormone in man Endocrinol J 43 Suppl 1996 57 63
10. A. Grimberg, and P. Cohen Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis J Cell Physiol 183 1 2000 1 9
11. B. Lunenfeld Androgen therapy in the aging male World J Urol 21 5 2003 292 305
12. M.E. Wallymahmed, P. Foy, and I.A. MacFarlane The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects Clin Endocrinol (Oxford) 51 3 1999 333 338
13. A. Gentili, T. Mulligan, and M. Godschalk Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men J Clin Endocrinol Metab 87 2 2002 825 834
14. A.J. Weissberger, and K.K. Ho Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization J Clin Endocrinol Metab 76 6 1993 1407 1412
15. S. Welle, C. Thornton, M. Start, and B. McHenry Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60-years-old J Clin Endocrinol Metab 81 9 1996 3239 3243
16. D. Rudman, A.G. Feller, and H.S. Nagraj Effects of human growth hormone in men over 60-years-old N Engl J Med 323 1 1990 1 6
17. P.J. Snyder, H. Peachey, and J.A. Berlin Effects of testosterone replacement in hypogonadal men J Clin Endocrinol Metab 85 8 2000 2670 2677
18. J.S. Tenover Effects of testosterone supplementation in the aging male J Clin Endocrinol Metab 75 4 1992 1092 1098
19. R.J. Urban, Y.H. Bodenburg, and C. Gilkison Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis Am J Physiol 269 1995 E820 E826
20. R. Sih, J.E. Morley, and F.E. Kaiser Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial J Clin Endocrinol Metab 82 6 1997 1661 1667
21. K.T. Brill, A.L. Weltman, and A. Gentili Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men J Clin Endocrinol Metab 87 12 2002 5649 5657
22. J.P. Span, G.F. Pieters, C.G. Sweep, A.R. Hermus, and A.G. Smals Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement J Clin Endocrinol Metab 85 3 2000 1121 1125
23. M.R. Blackman, J.D. Sorkin, and T. Munzer Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial JAMA 288 18 2002 2282 2292
24. E.L. Rhoden, and A. Morgentaler Risks of testosterone-replacement therapy and recommendations for monitoring N Engl J Med 350 5 2004 482 492
25. E.J. Duschek, L.J. Gooren, and J.C. Netelenbos Effects of raloxifene on gonadotophins, sex hormones, bone turnover and lipids in healthy elderly men Eur J Endocrinol 150 2004 539 546
26. Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000;(2):CD000151.
27. B.L. Riggs, and L.C. Hartmann Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice N Engl J Med 348 7 2003 618 629
28. B. Andersson, G. Johannsson, and G. Holm Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial J Clin Endocrinol Metab 87 1 2002 122 128
29. K.K. Ho, A.J. O'Sullivan, T. Wolthers, and K.C. Leung Metabolic effects of oestrogens: impact of the route of administration Ann Endocrinol 64 2 2003 170 177
30. H.J. Cardim, C.M. Lopes, D. Giannella-Neto, A.M. da Fonseca, and J.A. Pinotti The insulin-like growth factor-I system and hormone replacement therapy Fertil Steril 75 2 2001 282 287
31. M. Paassilta, A. Karjalainen, and K. Kervinen Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels Atherosclerosis 149 1 2000 157 162
32. A.J. Weissberger, K.K. Ho, and L. Lazarus Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin- like growth factor I, and GH-binding protein in postmenopausal women J Clin Endocrinol Metab 72 2 1991 374 381
33. A. Cano, C. Castelo-Branco, and J.J. Tarin Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-l, and IGFBP-3 levels Fertil Steril 71 2 1999 261 267
34. D. Goodman-Gruen, and E. Barrett-Connor Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study J Clin Endocrinol Metab 81 12 1996 4268 4271
35. P. van Kesteren, P. Lips, and W. Deville The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals J Clin Endocrinol Metab 81 6 1996 2227 2232
36. A. Hameed, T. Brothwood, and P. Bouloux Delivery of testosterone replacement therapy Curr Opin Invest Drugs 4 10 2003 1213 1219
37. N.C. Park, B.Q. Yan, J.M. Chung, and K.M. Lee Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency Aging Male 6 2 2003 86 93
38. K. Landin-Wilhelmsen, L. Wilhelmsen, and G. Lappas Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin Clin Endocrinol 41 3 1994 351 357
39. A.M. Oleksik, T. Duong, N. Pliester, G. Asma, C. Popp-Snijders, and P. Lips Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis J Clin Endocrinol Metab 86 6 2001 2763 2768
40. R.P. Rooman, L.O. De Beeck, M. Martin, J. Van Doom, S. Mohan, and M.V. Du Caju IGF-I, IGF-II 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls Eur J Endocrinol 146 6 2002 823 829
41. W. Vongpatanasin, M. Tuncel, Z. Wang, D. Arbique, B. Mehrad, and I. Jialal Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women J Am Coll Cardiol 41 8 2003 1358 1363
42. L.J. Murphy Friesen HG Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat Endocrinology 122 1 1988 325 332
43. R.J. Borski, W. Tsai, R. DeMott-Friberg, and A.L. Barkan Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I gene expression and secretion Endocrinology 137 8 1996 3253 3259
44. R. Krattenmacher, R. Knauthe, K. Parczyk, A. Walker, U. Hilgenfeldt, and K.H. Fritzemeier Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects J Steroid Biochem Mol Biol 48 2-3 1994 207 214
45. L. De Marinis, A. Mancini, and D. Izzi Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer Clin Endocrinol 52 6 2000 681 685
46. S.M. Corsello, C.A. Rota, and P. Putignano Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer Eur J Endocrinol 139 3 1998 309 313
47. R. Attanasio, M. Barausse, and R. Cozzi Raloxifene lowers IGF-I levels in acromegalic women Eur J Endocrinol 148 4 2003 443 448
48. B. Fournier, S. Gutzwiller, T. Dittmar, G. Matthias, P. Steenbergh, and P. Matthias Estrogen receptor (ER)-alpha, but not ER-beta, mediates regulation of the insulin-like growth factor I gene by antiestrogens J Biol Chem 276 38 2001 35444 35449
49. W.B. Wehrenberg, A. Baird, S.Y. Ying, and N. Ling The effects of testosterone and estrogen on the pituitary growth hormone response to growth hormone-releasing factor Biol Reprod 32 2 1985 369 375
50. H. Asscheman, L.J. Gooren, J.A. Megens, J. Nauta, H.J. Kloosterboer, and F. Eikelboom Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol Metabolism 43 8 1994 935 939
51. A.J. Conway, L.M. Boylan, C. Howe, G. Ross, and D.J. Handelsman Randomized clinical trial of testosterone replacement therapy in hypogonadal men Int J Androl 11 4 1988 247 264
52. K. Link, R.M. Blizzard, W.S. Evans, D.L. Kaiser, M.W. Parker, and A.D. Rogol The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males J Clin Endocrinol Metab 62 1 1986 159 164
53. L. Liu, G.R. Merriam, and R.J. Sherins Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism J Clin Endocrinol Metab 64 4 1987 651 656
54. D.A. Fryburg, A. Weltman, and L.A. Jahn Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes J Clin Endocrinol Metab 82 11 1997 3710 3719
55. A. Giustina, T. Scalvini, and C. Tassi Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone J Clin Endocrinol Metab 82 4 1997 1210 1219
56. M. Phillip, T. Palese, E.R. Hernandez, C.T. Roberts Jr., D. LeRoith, and A.A. Kowarski Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat Endocrinology 130 5 1992 2865 2870
57. N. Mauras, K.O. O'Brien, K.O. Klein, and V. Hayes Estrogen suppression in males: metabolic effects J Clin Endocrinol Metab 85 7 2000 2370 2377
58. D.L. Metzger, and J.R. Kerrigan Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence J Clin Endocrinol Metab 79 2 1994 513 518
59. M. Bondanelli, M.R. Ambrosio, A. Margutti, P. Franceschetti, M.C. Zatelli, and E.C. degli Uberti Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone Neuroendocrinology 77 6 2003 380 387